The most promising targets include inhibitors of B-cells, tyrosine kinases, 5-hydroxytryptamin receptors, interleukin-6 and Wnt signalling. PubMed, Curr Opin Pharmacol, 2013 Jun;13(3):455-62. (Also see: Skin Fibrosis, and Pulmonary Fibrosis Research)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.